With more than 20,000 workers worldwide, drug-research company Charles River Laboratories (CRL) is the largest provider of discovery, data, nonclinical development, and drug safety testing services worldwide. The Massachusetts-based company was instrumental in the process of drug development for 85% of FDA-approved studies in 2021.
As part of that process, CRL processes tens of thousands of documents for clients every year with tight timelines and high degrees of quality expected. These documents form a key component of drug companies’ submission pipeline for drug approvals. Today, Charles River Laboratories leverages the power of metadata to optimize study processes, saving time, costs, and manual labor, while also optimizing ROI.
With M-Files, Charles River Laboratories was able to achieve:
- $2.4 million estimated annual savings and operational improvements from centralized document process automation.
- 9,600 hours saved per year in automated workflows
- $326,400 annual savings in DocuSign costs
Read the full story: Charles River Laboratories Case Study
